{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:51:45Z","timestamp":1791525105347,"version":"4.3.4"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) is characterized by the accumulation of amyloid-\u03b2 (A\u03b2) plaques and tau pathology, with mTORC1 hyperactivation implicated in disease pathogenesis via suppression of autophagy. However, systematic evidence regarding its key upstream repressor, TSC1, in human AD brains remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using an integrated, multi-level bioinformatic approach combining RNA-seq, neuropathological, and clinical data from the ROSMAP cohort, we comprehensively investigated the TSC1-mTORC1 axis in AD. Gene co-expression network analysis and gene set enrichment analysis were applied to contextualize TSC1 within disease-associated molecular networks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our analysis revealed significant TSC1 downregulation and concomitant mTOR and RPTOR upregulation in AD brains. Critically, lower TSC1 expression was strongly correlated with higher A\u03b2 plaque density, greater tau tangle burden, worse global cognitive performance, and an exacerbated neuroinflammatory microenvironment characterized by increased microglial and astrocytic activation. Gene co-expression network analysis positioned TSC1 within a disease-associated module showing the strongest association with AD pathology. Gene set enrichment analyses further demonstrated that the TSC1 low-expression phenotype was associated not only with suppression of autophagy-related pathways but also with significant enrichment of broad pro-inflammatory and immune response pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and discussion<\/jats:title>\n                    <jats:p>These integrated human data provide compelling evidence that TSC1 deficiency is a hallmark of AD and is associated with mTORC1 hyperactivation, aggravated amyloid-tau pathologies, cognitive impairment, and neuroinflammation. These findings are consistent with a model in which TSC1 deficiency and mTORC1 hyperactivation may contribute to AD pathophysiology, thereby nominating the TSC1-mTORC1 axis and its associated inflammatory networks as promising multi-faceted therapeutic targets. Future replication in independent cohorts is warranted to assess the generalizability of these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2026.1920487","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:30:19Z","timestamp":1791523819000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["TSC1-mTORC1 signaling in Alzheimer\u2019s disease: an integrated bioinformatic analysis linking gene expression to neuropathology"],"prefix":"10.3389","volume":"18","author":[{"given":"Zheng","family":"Liu","sequence":"first","affiliation":[{"name":"School of Basic Medicine, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Yu","sequence":"additional","affiliation":[{"name":"College of Integrated Chinese and Western Medicine, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuohan","family":"Ning","sequence":"additional","affiliation":[{"name":"Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongshuai","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqi","family":"Li","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Fan","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaolong","family":"Lu","sequence":"additional","affiliation":[{"name":"Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg3897","article-title":"TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy","volume":"7","author":"Alquezar","year":"2021","journal-title":"Sci. Adv."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer's disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrn3068","article-title":"Fighting neurodegeneration with rapamycin: mechanistic insights","volume":"12","author":"Bov\u00e9","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1074\/jbc.M110.180638","article-title":"Naturally secreted amyloid-\u03b2 increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism","volume":"286","author":"Caccamo","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.bbadis.2013.04.013","article-title":"Impairment of proteostasis network in down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain","volume":"1832","author":"Di Domenico","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/sj.cdd.4402194","article-title":"The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation","volume":"14","author":"Fernandes-Alnemri","year":"2007","journal-title":"Cell Death Differ."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease","volume":"8","author":"Finner","year":"2021","journal-title":"Sci. Data"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1038\/s41467-018-06449-x","article-title":"Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model","volume":"9","author":"Flores","year":"2018","journal-title":"Nat. Commun."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/ni.2913","article-title":"The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation","volume":"15","author":"Franklin","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1016\/j.celrep.2020.02.025","article-title":"\u0392-Amyloid clustering around ASC fibrils boosts its toxicity in microglia","volume":"30","author":"Friker","year":"2020","journal-title":"Cell Rep."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural mechanisms of NLRP3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer's disease facts and figures","volume":"12","author":"Gaugler","year":"2016","journal-title":"Alzheimers Dement."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"8078","DOI":"10.1111\/jcmm.15439","article-title":"New mechanism of nerve injury in Alzheimer's disease: \u03b2-amyloid-induced neuronal pyroptosis","volume":"24","author":"Han","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion","volume":"25","author":"He","year":"2015","journal-title":"Cell Res."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","article-title":"Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3","volume":"604","author":"Hochheiser","year":"2022","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e8689","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn2967","article-title":"Amyloid-\u03b2 and tau\u2014a toxic pas de deux in Alzheimer's disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"14305","DOI":"10.1038\/s41598-024-65248-1","article-title":"The impact of astrocytic NF-\u03baB on healthy and Alzheimer's disease brains","volume":"14","author":"Jong Huat","year":"2024","journal-title":"Sci. Rep."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.fob.2014.07.006","article-title":"mTOR inhibition increases cell viability via autophagy induction during endoplasmic reticulum stress\u2014an experimental and modeling study","volume":"4","author":"Kapuy","year":"2014","journal-title":"FEBS Open Bio"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4049\/jimmunol.2200550","article-title":"Antisense oligonucleotide therapy decreases IL-1\u03b2 expression and prolongs survival in mutant Nlrp3 mice","volume":"211","author":"Kaufmann","year":"2023","journal-title":"J. Immunol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","article-title":"Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal \u03b2-catenin pathway function in an Alzheimer's disease model","volume":"187","author":"Kitazawa","year":"2011","journal-title":"J. Immunol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1474-9726.2011.00791.x","article-title":"Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1\u03b2 and enhancing NMDA signaling","volume":"11","author":"Majumder","year":"2012","journal-title":"Aging Cell"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"114216","DOI":"10.1016\/j.celrep.2024.114216","article-title":"Microglia-astrocyte crosstalk in the amyloid plaque niche of an Alzheimer's disease mouse model, as revealed by spatial transcriptomics","volume":"43","author":"Mallach","year":"2024","journal-title":"Cell Rep."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/gm452","article-title":"Genes and pathways underlying regional and cell type changes in Alzheimer's disease","volume":"5","author":"Miller","year":"2013","journal-title":"Genome Med."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jalz.2016.08.015","article-title":"mTOR and neuronal cell cycle reentry: how impaired brain insulin signaling promotes Alzheimer's disease","volume":"13","author":"Norambuena","year":"2017","journal-title":"Alzheimers Dement."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40659-022-00404-3","article-title":"Inflammation context in Alzheimer's disease, a relationship intricate to define","volume":"55","author":"Novoa","year":"2022","journal-title":"Biol. Res."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2741\/S310","article-title":"The role of mTOR signaling in Alzheimer disease","author":"Oddo","year":"2012","journal-title":"Front. Biosci."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbd.2015.03.014","article-title":"mTOR signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy","volume":"84","author":"Perluigi","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.exger.2014.12.002","article-title":"How longevity research can lead to therapies for Alzheimer's disease: the rapamycin story","volume":"68","author":"Richardson","year":"2015","journal-title":"Exp. Gerontol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1523\/JNEUROSCI.2427-21.2022","article-title":"Microglial mTOR activation upregulates Trem2 and enhances \u03b2-amyloid plaque clearance in the 5XFAD Alzheimer's disease model","volume":"42","author":"Shi","year":"2022","journal-title":"J. Neurosci."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e9979","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-\u03b2 levels in a mouse model of Alzheimer's disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3233\/JAD-131124","article-title":"Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer's disease","volume":"38","author":"Sun","year":"2014","journal-title":"J. Alzheimer's Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/jnc.13037","article-title":"Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD","volume":"133","author":"Tramutola","year":"2015","journal-title":"J. Neurochem."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/ncb999","article-title":"Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins","volume":"5","author":"Zhang","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s43587-024-00792-z","article-title":"Modulating mTOR-dependent astrocyte substate transitions to alleviate neurodegeneration","volume":"5","author":"Zhang","year":"2025","journal-title":"Nat. Aging"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1920487\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:30:20Z","timestamp":1791523820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1920487\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":40,"alternative-id":["10.3389\/fnagi.2026.1920487"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1920487","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"article-number":"1920487"}}